Health Care & Life Sciences » Pharmaceuticals | Shield Therapeutics PLC

Shield Therapeutics PLC

Shield Therapeutics PLC
Stock Exchange London Stock Exchange
EPS
GBP0.02
Market Cap
GBP127.04 M
Shares Outstanding
117.09 M
Public Float
19.9 M

Profile

Address
Northern Design Centre
Gatehead Quays GH NE8 3DF
United Kingdom
Employees -
Website http://shieldtherapeutics.com
Updated 07/08/2019
Shield Therapeutics Plc is a pharmaceutical company. It engages in the development and commercialization of secondary care focused pharmaceuticals. Its products include Feraccru, which treats oral problems with iron deficiency anaemia; and PT20, which treats hyperphosphatemia.

Financials

View All

Carl Sterritt
Chief Executive Officer & Executive Director
Hans-Peter Hasler
Non-Executive Director